Thank you for taking the time to join today’s call.
Today, I’m joined by Dan Luckshire, our CFO, and we are pleased to have this opportunity to provide a quarterly update on our achievements and upcoming objectives.
will financial business update. I will and call, a provide this provide update a Dan On
we’re together. I by which something acknowledging like the still would to pandemic, we start recognize this call all navigating is
its With regard pandemic, general on COVID-XX to the business upon potential to and we our population. impact continue the monitor
who and with are by sector this to globe we fortunate tirelessly with dramatically adversely At pandemic all bring Our any tools this and the pandemic help in are who’ve thoughts working public in impacted here disease not develop and around been those in those the the to U.S. continue devastating material the under has respect. impacted business control. that SIGA, our be to the private
continue challenging accomplish perform while during employees to business growth the evident on to remotely. primarily due multiple and grow and ways XXXX SIGA’s period, are we development the performance our effective incredibly find is the and to we front, hard of operating this the fronts: front front. well ensure partners goals In regulatory work our working in which fact, predominantly and to
operating front, timely under September, been deliveries approximately the or Stockpile to XXX,XXX XXC total TPOXX the delivering we TPOXX brings oral basis oral In XXX,XXX XX-Q first on reflected SNS results. XXXX in we for the BARDA a contract. courses financial courses, approximately of National Strategic have the delivered X of the to On which TPOXX is SNS. months This
delivery courses fourth in will SNS another to October. Additionally, quarter This the the XXX,XXX approximate TPOXX reflected oral delivered we financial results. of be in
of cumulatively represents by and TPOXX. with PHAC XX,XXX contract the Canada TPOXX position PHAC, Canada. issued would of the Public X building at announced the front, award intention the international Canadian of contract approximately to an PHAC the contract oral by years then a overall announcement courses A PHAC to distinct in military development similar combination Canadian revenues of or April, contract, military generate the oral of the market and SIGA PHAC in procurement if XX,XXX the up a another separate X-year are executed for Canadian approximately over its contract step deliver to TPOXX process This up $XX with deliveries business to is If exercised. military Health pricing Agency to the of for over period. up the pricing to next would time cumulative courses the in to all options million On to
on the Going expect with forward, build we to another international the months. X within Canadian purchases next order
expect be the annual order to a order contract. next an will multiyear likely opposed as We
and over and and range a to good for TPOXX TPOXX. placed on the within to prospects XX believe good Beyond to broadly, oral countries for The increase pandemic we be contracts the additional are for conversations we some believe term, preparedness which to of next continue slowed advance SIGA broad will with it but few orders has in months. conversations COVID-XX anticipated orders pandemic months, international the focus short is continue orders X and/or next
touch set filings, appropriate TPOXX to initiatives, soon TPOXX as at regulatory pursue of complications. to indications briefly the and support of it file plan in same MAA likely as for addresses in a prophylaxis indications the the and regulatory I a programs. a and to this of cowpox, in TPOXX TPOXX to of of with a as this With of IV Europe people the to for for smallpox, a X for important year late starting to respect at postexposure NDA similar in submission oral jurisdictions forward Canada including in would smallpox to when outbreak. the with domestic We year. time. year plan an the these this be period, on MAA program filing the monkeypox with prophylaxis of in submission that U.S. end planned first With oral or activity Subsequent and FDA it filed postexposure earlier quarter vaccinia with continue of respect in the we On an program XX-month the PEP, the TPOXX XXXX. to regulatory as is submissions application includes pace, label IV early that Health to majority for a Europe treatment a we and the plan fast Canada regulatory The continues event expansion front, make development use within discussions in for like submission press oral X
such, discussion merits is the increasing about the the As important program an PEP of in size the element government U.S. overall of the with SNS. the
sick early an on XXXX. capsule. important IV this IV unable the next of would update this supplement a to available is ensure the TPOXX quarter oral the We XXXX. in in expect regard or oral the we program as From U.S. to update an be earlier as to it TPOXX FDA in public file swallow status program this perspective, to with those to to seeks With health too will quarterly first noted provide call, a NDA the program, for
point, important continues At the formulation to Finally, the the call population update. by pediatric like BARDA’s covered TPOXX and to turn financial current conduct XX the those I be label, would SIGA not of development over support, kilograms unable for would work swallow are on a to suspension Dan those serve who under to capsules. that with this liquid to